, 1997). All experiments were performed Ibrutinib at room temperature (24–26 °C). In brief, freely moving rats were kept in a plexiglass recording chamber (5 L) that was flushed continuously with a mixture of 79% nitrogen and 21% oxygen (unless otherwise required by the protocol) at a rate of 1 L/min. The concentrations of O2 and CO2 in the chamber were monitored on-line

using a fast-response O2/CO2 monitor (ADInstruments, NSW, Australia). The pressure signal was amplified, filtered, recorded, and analyzed off-line using Powerlab software (Powerlab 16/30, ML880/P, ADInstruments, NSW, Australia). The values of fR and VT analyzed were those recorded for 2 min before the exposure to the stimulus and for 2 more min at the end of each stimulus, when breathing stabilized. Changes in the fR, VT, and minute ventilation ( V˙E) (fR × VT; ml/min/kg) were averaged and

expressed as means ± SEM. The mean arterial pressure, the discharge of the phrenic and splanchnic nerves and the tracheal O2 and CO2 were recorded as previously described (Moreira et al., 2006 and Moreira et al., 2007). Before starting the experiments, the ventilation was adjusted to have the ETCO2 at 3–4% at steady-state (60–80 cycles/s; tidal volume 1–1.2 ml/100 g). This condition was selected because 3–4% end-expiratory CO2 was below the threshold of the PND. Variable amounts

of pure CO2 were added to the breathing mixture to adjust Trichostatin A clinical trial ETCO2 to the desired level. All analog data (ETCO2, sSND, PND and MAP) were stored on a computer via a micro1401 digitizer (Cambridge Electronic Design) and were processed off-line using version 6 of the Spike 2 software (Cambridge Electronic Design) as described previously (Takakura et al., 2006 and Takakura et al., 2011). The integrated phrenic nerve discharge (iPND) and the integrated splanchnic nerve discharge ID-8 (iSND) were obtained after the rectification and smoothing (τ = 0.015 and 2 s, respectively) of the original signal, which was acquired with a 30–300 Hz bandpass. Neural minute × volume (mvPND, a measure of the total phrenic nerve discharge per unit of time) was determined by averaging the iPND over 50 s and normalizing the result by assigning a value of 0 to the dependent variable recorded at the low levels of end-expiratory CO2 (below threshold) and a value of 1 at the highest level of PCO2PCO2 investigated (between 9.5 and 10%). The iSND was normalized for each animal by assigning the value of 100 to the resting SNA and the value of 0 to the minimum value recorded either during the administration of a dose of phenylephrine that saturated the baroreflex (5 μg/kg, i.v.) or after the ganglionic blockade (hexamethonium; 10 mg/kg, i.v.).